Skip to main content
. 2021 Feb;13(2):735–742. doi: 10.21037/jtd-20-2736

Table 1. Comparison of preoperative variables.

Variables Total (n=582) PMV (n=259) Non-PMV (n=323) P valuea
Demographic data
   Age (year) 52.2±12.7 53.6±12.4 51.1±12.8 0.027
   Male (%) 433 (74.4) 191 (73.3) 242 (74.9) 0.746
   BMI (kg/m2) 25.5±5.0 26.5±5.0 25.0±5.0 0.003
Medical history
   Hypertension (%) 413 (71.0) 192 (74.1) 221 (68.4) 0.132
   Diabetes mellitus (%) 11 (1.9) 4 (1.5) 7 (2.2) 0.762
   Previous cardiac surgery (%) 28 (4.8) 7 (2.7) 21 (6.5) 0.033
   Previous coronary artery disease (%) 21 (3.6) 13 (5.0) 8 (2.5) 0.102
   Cerebrovascular disease (%) 20 (3.4) 9 (3.5) 11 (3.4) 0.964
LVEF (%) 57.0 (54.0, 60.0) 57.0 (55.0, 59.0) 57.5 (54.0, 60.0) 0.559
Pericardial effusion (%) 21 (3.6) 12 (4.6) 9 (2.8) 0.235
Preoperative laboratory data
   WBC (109/L) 11.1±4.1 11.6±4.3 10.8±3.8 0.015
   PLT (109/L) 145.2±67.5 128.6±64.4 158.5±67.0 <0.001
   Hb (g/L) 119.2±25.9 114.7±26.8 122.8±24.6 <0.001
   CRP 27.7 (5.4, 89.5) 31.2 (5.6, 101.9) 26.2 (5.2, 83.1) 0.163
   PCT 1.0 (0.3, 3.6) 1.7 (0.5, 6.2) 0.7 (0.2, 2.4) <0.001
   sCr (ìmol/L) 102.6±72.1 120.0±84.8 88.6±56.3 <0.001
   sCyC 1.1±0.7 1.3±0.8 1.0±0.6 <0.001
   ALB (g/L) 36.2±4.9 35.5±5.2 36.9±4.6 <0.001
   Fibrinogen (g/L) 2.3 (1.6, 3.2) 2.1 (1.5, 2.9) 2.4 (1.8, 3.4) <0.001
   Triglyceride (mmol/L) 1.0 (0.7, 1.5) 1.1 (0.8, 1.7) 1.0 (0.7, 1.4) 0.009
   D-dimer (ng/mL) 4.5 (2.4, 9.3) 5.3 (2.7, 13.0) 4.1 (2.2, 7.7) 0.002

Data presented as n (%); median (IQR). a, P values indicate differences between PMV and Non-PMV groups. P<0.05 was considered statistically significant. PMV, prolonged mechanical ventilation; BMI, body mass index; LVEF, left ventricular ejection fraction; WBC, white blood cell; PLT, platelet; Hb, hemoglobin; CRP, c reactive protein; sCr, serum creatinine; sCyC, serum cystatin C; ALB, albumin;